Showing posts with label etoposide. Show all posts
Showing posts with label etoposide. Show all posts
Thursday, April 12, 2012
Current Drug Shortages: Etoposide solution for injection (updated)
Current Drug Shortages: Etoposide solution for injection (updated):
Bedford Laboratories has 100mg/5ml available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. All other presentations are out os stock and the company cannot estimate a release date. Production is pending as capacity permits. Availability of products is updated on the Bedford Laboratories website. Etoposide Injection 20 mg/mL; 5 mL; 53776 vials in stock; approximately 45000 vials will be in warehouse by the 3rd week of this month.
add your opinions
drug shortages
,
etoposide
Thursday, February 16, 2012
abstract: Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary
Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary: Publication year: 2012
Source: Gynecologic Oncology Case Reports, Available online 13 February 2012
abstract
Highlights
► Ovarian small-cell carcinoma of the hypercalcemic type is a rare neoplasm with no standard treatment.► The chemotherapy regimen including vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin and etoposide (VPCBAE) is safe and effective.has limited toxicities and was effective in the 3 patients described in this case report.
add your opinions
bleomycin
,
Cisplatin
,
Cyclophosphamide
,
doxorubicin
,
etoposide
,
hypercalcemic type
,
ovarian small-cell
,
vinblastine
Subscribe to:
Posts
(
Atom
)